Demecan

Ebersbach, Germany · Founded 2017 · Privately Held (backing)

Producer and supplier of cannabis intended to be used for medicinal drug research and development process. Demecan is based in Ebersbach, Germany and was founded in 2017. Its last known valuation is $109 million. It has raised $23.4 million.

Last price · $/share
—
Implied valuation
$108.8M
Total raised
$23.4M
Last round
—

Who backs Demecan?

10 investors
InvestorType
b2ventureVenture capital
BMH Beteiligungs-Managementgesellschaft HessenVenture capital
Trog Hawley CapitalFamily office
PHK Enterprise Family OfficeFamily office
Enexis (Sweden)—
Futury Capital—
Krombacher—
Mittelständische Beteiligungsgesellschaft Sachsen—
Scope Hanson—
Wayland Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Demecan investors

Free account
More of Demecan with a free account
  • ·Watch Demecan: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Demecan. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View